Sai Parenterals Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Sai Parenterals Ltd is ₹ 489.35 as of 05 May 15:30 . The P/E Ratio of Sai Parenterals Ltd is 0 as of March 2023 .The P/E Ratio of Sanofi Consumer Healthcare India Ltd is 0 as of March 2023 . The Market Cap of Sai Parenterals Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of March 2023 . The revenue of Sai Parenterals Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Dec '25 revenue of ₹ 255.6 crore. This represent the decline of -8.14% The ebitda of Sai Parenterals Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Dec '25 ebitda of ₹ 94.4 crore. This represent the decline of 0% The net profit of Sai Parenterals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 62.7 crore to ₹ 67.8 crore over 7 quarters. This represents a CAGR of 4.57% The dividend payout of Sai Parenterals Ltd changed from 0 % to 0 % over 5 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % to 0 % over 5 quarters. This represents a CAGR of -100.00% .

About Sai Parenterals Ltd

Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Sai Parenterals Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Sai Parenterals Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Sai Parenterals Ltd is 2,161 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 10,577 Cr

What are the key factors driving the stock performance of Sai Parenterals Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Sai Parenterals Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sai Parenterals Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 5, 2026, the Sai Parenterals Ltd stock price is INR ₹489.35. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4592.6.

How do dividend payouts of Sai Parenterals Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Sai Parenterals Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.